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Introduction
Cardiovascular diseases (CVD) are considered the principle
cause of death in most countries (Hennekens, 1998). Elevated
levels of oxidative stress markers were detected in numerous
cardiovascular disorders in human including hypertension,
ventricular hypertrophy, atherosclerosis and congestive heart
failure (Carlos et al., 1998; Keith et al., 1998; Miller et al., 1998;
Suzuki et al., 1998; Gokce et al., 1999; Harjai, 1999; Miwa et al.,
1999; Buffon et al., 2000). In addition, many studies have
shown increases in biomarkers of oxidant production and/or
decreases in antioxidant potential in cardiovascular disorders
in animals (Chintala et al., 1992 and Sagols and Priymenko,
2011).
Normally, oxygen is used by the mitochondria in the ox-
idative phosphorylation process and for the production of
adenosine triphosphate (Abd Ellah, 2010). Lack of oxygen sup-
ply as in cases of hypoxia or ischemia upsets the mitochondrial
electron transport chain, which consequently result in the ac-
cumulation of toxic metabolites, followed by cell death
(Lemasters et al., 1997). Reactive oxygen species (ROS) formed
during mitochondrial electron transport are removed by the
antioxidant defense. The intracellular antioxidant defense
chain can be overwhelmed by the generation of huge
amounts of ROS, causing lipid peroxidation and DNA breaks
(Ambrosio and Tritto, 1999).
Sources of free radicals
Under normal physiological conditions, ROS are produced
in low concentrations, which are helpful in regulating vascular
smooth muscle cell contaction, relaxation and growth. On the
other hand, excess production of ROS could result in cardiac
and vascular dysfunction.
Mitochondria represent the main source for ROS intracel-
lularly under normal physiological conditions. Other sources
include induction of cytosolic oxidases such as xanthine oxi-
dase (XO), NADH/NADPH oxidase and nitric oxide synthase
(NOS). XO generates superoxide anion, this enzyme is present
mainly in the intestinal mucosa and in the liver. Thea activity
of XO is enhanced during chronic hypoxia and in the presence
of cytokines. It has been reported that activity of XO together
with superoxide increased in the mesenteric tissue in animal
model of hypertension, which may be responsible for intensi-
fying vascular tone (Suzuki et al., 1998), this assumption was
supported by the findings of Houston et al. (1999), who sug-
gested that XO could be concentrated several fold in the vas-
cular tissues and may play significant role in dysfunction of
the endothelium in atherosclerotic humans and hypercholes-
terolemic rabbits.
Free radicals are produced by many immune cells, which
used to kill ingested pathogen as a means of host defense.
These immune cells act as a source for production of oxidants
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in an acute inflammatory response. Infiltration of tissues es-
pecially with neutrophils during post ischemic reperfusion is
associated with cell death and tissue injury, which caused by
the secreation of ROS and proteolytic enzymes. This assump-
tion was supported by the findings of Buerke et al. (1994), who
observed that reperfusion cardiac injury in feline is reduced
after inhibition of neutrophils migration.
Phagocytic cells play an important role in defense against
infection by the release of large amount of superoxide that is
formed by the enzyme NADH/NADPH oxidase. This enzyme
is established to be the source for superoxide production in
the vascular tissues (Bayraktutan et al., 1998; Di Wang et al.,
1999), under the effect of angiotensin II, higher production of
superoxide has been involved in the pathogenesis of an-
giotensin II induced vascular hypertrophy and endothelial cell
dysfunction (Griendling et al., 1994; Rajagopalan et al., 1996;
Ushio-Fukai et al., 1998; Watta- napitayakul et al., 2000).
Oxidative stress in cardiovascular diseases
Oxidative stress was reported to be involved in the patho-
genesis of many cardiovascular diseases, including myocardial
infarction (MI), coronary disease, congestive heart failure (Mak
and Weglicki, 1990; Belch et al., 1991; Kaul et al., 1993; Mc-
Murray et al., 1993; Nakamura et al., 2001; Serdar et al., 2001;
Freeman et al., 2005; Giordano, 2005; Wojciechowska et al.,
2014) and in the pathophysiology of atherosclerosis (Moreno
and Fuster, 2004), diabetic cardiomyopathy (Bugger and Abel,
2010; Khullar et al., 2010), congestive cardiomyopathy
(Pankuweit et al., 2004) and hypertensive heart disease (Shah-
baz et al., 2010).
Reactive oxygen species have been implicated as a con-
tributor to endothelial dysfunction, and reported to be a
mojor cause of endothelial dysfunction in atherosclerosis (Cai
and Harrison, 2000). Oxidative stress plays an important role
in the pathogenesis of atherosclerosis through the production
of ROS in the wall of the blood vessels, which could result in
endothelial dysfunction (Channon and Guzik, 2002; Lee et al.,
2012) and may produce damage to the cellular components
of the vascular wall. An experimental study done by Liao et al.
(1994) revealed that ROS involved in the development of ath-
erosclerosis through the production of lipid peroxidation
products and in another study by activation of matrix metal-
loproteinases (Rajagopalan et al., 1996)
Studies reported that increase the production of superox-
ide from the mitochondria in pathological conditions results
in modification of mitochondrial DNA, which can lead to func-
tional changes in the cell. Several studies have reported the
presence of a correlation between DNA damage and athero-
sclerosis (Martinet et al., 2001). Reportedly, ROS can inhibit
the sarcoplasmic reticulum Ca2+ pump in the cardiac contrac-
tion - relaxation cycle, which have direct impact on myocardial
function (Matsubara and Dhalla, 1996; Temsah et al., 1999). 
Myocardial infarction was reduced in dogs infused with
SOD and catalase after coronary occlusion and reperfusion,
which suggested the involvement of free radicals such as su-
peroxide anion and hydroxyl radicals (Jolly et al., 1984), in is-
chemia–reperfusion injury (Bolli, 1988; Ferrari et al., 1998).
Ischemic reperfusion was reported to cause functional and
structural alterations in the myocardium (Bolli et al., 1988).
Moreover, Yasmin et al. (1997) demonstrated that reperfusion
is associated with increased production of nitric oxide that in-
teracts with superoxide anion to form peroxynitrite, which may
play a role in the development of cardiac dysfunction. In ad-
dition, Randhawa and Singal (1992) documented the role of
oxidative stress in myocardial stunning using spin-trap tech-
nique, where the production of free radicals was suppressed
and myocardial stunning was attenuated after antioxidants
therapy (Bolli, 1988).
Several studies proved that cytokines like interleukin,
tumor necrosis factor and growth factors are pro-oxidants
were elevated in plasma in patients with heart disease (Torre-
Amione et al., 1996; Djurovic et al., 1999; Ueda et al., 1999;
Ruotolo et al., 2000), and mediate cardiac dysfunction through
the production of nitric oxide (NO) (Schulz et al., 1995; Wildhirt
et al., 1995; Sawyer and Colucci, 1998).
Oxidative stress has been reported to contribute in the de-
velopment of cardiac dysfunction in experimental animals
(Chen et al., 2009; Ahmed et al., 2010). The pathogenesis of
heart failure subsequent to myocardial infarction (MI) in rats
was attributed to the involvement of free radicals, which re-
sulted in changes in myocardial antioxidants with a state of
oxidative stress, and lipid peroxidation in the early stage.  In
late stages of MI, the activities of glutathione peroxidase
(GSH-Px), catalase, superoxide dismutase (SOD) and the vita-
min E level in the myocardial tissues were decreased as re-
ported by Hill and Singal (1996). 
In an experimental study on animals, the levels of antiox-
idants were measured in the two ventricles during the seque-
lae of heart failure, oxidative stress was developed firstly in
the left ventricle, followed by decrease antioxidants levels in
the right ventricle in chronic stage of the disease (Hill and Sin-
gal, 1996, 1997). In vitro studies by Cheng et al. (1995) and Pi-
mentel et al. (2001), ROS production was increased during
overstretching of cardiomyocytes, which may be involved in
in mediating contractile dysfunction. Furthermore, in an ex-
perimental induction of heart failure in guinea pigs, done by
Dhalla et al. (1996), the authors observed that increased ox-
idative stress was occurred in the transition phase from my-
ocardial hypertrophy to heart failure. In another study in a
guinea pig model of heart failure subsequent to banding of
the ascending aorta, myocardial antioxidant reserve in the
form of SOD and GSHPx was decreased, which associated with
increased oxidative stress (Randhawa and Singal, 1992), the
authors added that, hypertrophy of the myocardial muscles
was developed at ten weeks and heart failure at 20 weeks post
surgery.
In vitro studies revealed that exposure of isolated perfused
hearts to free radicals resulted in decreased high energy phos-
phates, structural abnormalities and difficulty in myocardial
contraction (Burton et al., 1984; Ytrehus et al., 1986; Gupta and
Singal, 1989). Auto-oxidation of catecholamines was found to
initiate the production of free radicals and the development
of cardiac dysfunction (Meerson, 1980; Singal et al., 1982,
1983). Furthermore, the depression of calcium transport in the
sarcoplasmic reticulum mediates the increased ROS in is-
chemia–reperfusion injury, as documented by Hess et al.
(1983).
Several research studies had reported that exposure of
cardiac preparations to free radical stress resulted in de-
pressed cardiac contraction, diminishing of energy production
and a state of lipid peroxidation (Mickelson et al., 1988; Gupta
and Singal, 1989; Kaul et al., 1993,). In another study, reduction
of contractile function was correlated with decrease in SOD,
glutathione and alpha tocopherol in the myocardial tissues,
and associated with increased hydrogen peroxide and lipid
peroxidation products (Gupta and Singal, 1989; Vaage, 1997). 
Markers of oxidative stress in cardiovascular
diseases
Malondialdehyde (MDA), is one of the final products of
lipid peroxidation, and mostly measured as a biomarker of ox-
idative stress (Valko et al., 2007; Abd Ellah et al., 2013). The de-
gree of oxidative stress is evaluated by measuring the
concentration of circulating oxidative products such as MDA
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and oxidized low-density lipoproteins (oxLDL) (Betteridge,
2000; Braunwald, 2008). MDA is a mediator that produce the
damaging effect of ROS on the cells of the cardiovascular sys-
tem (Giordano, 2005), that was reported to increase in blood
in case of heart failure in humans and animals (Mak and
Weglicki, 1990; McMurray et a., 1990; Diaz-Velez et al., 1996;
Freeman et al., 1999; Nakamura et al., 2001; Serdar, et al., 2001;
Polidori et al., 2002; Boswood et al., 2008; Wojciechowska et
al., 2014). A significant relationship between blood MDA level
and heart disease was observed in dogs (Dhalla et al., 1996).
In addition, the severity of heart failure was directly correlated
with the increase in lipid peroxidation (Sobotka et al., 1993;
Diaz-Velez et al., 1996). Moreover, increased MDA, SOD and
glutathione levels were reported in congestive heart failure
patients (Belch et al., 1991; McMurray et al., 1990; 1993).
Oxidized LDL (oxLDL) is known as a part of the atheroscle-
rosis in humans (Witztum and Steinberg, 2001), which re-
ported to increase in human patients with coronary artery
disease. Moreover, oxLDL mediate apoptosis in human coro-
nary smooth muscle cells (de Nigris et al., 2000; Sugamura and
Keaney, 2011). Blood oxLDL level has been proposed as a use-
ful predictor of coronary disease and of mortality in human
patients (Tsutsui et al., 2002; Wu et al., 2006).
Role of antioxidants in cardiovascular diseases
Antioxidant vitamins, such as ascorbic acid, beta carotene
and alpha tocopherol counteract the excess free radiclas and
thus prevent lipid peroxidation and diminish atherogenesis
and the risk of coronary heart disease. Alpha tocopherol acts
to protect polyunsaturated fatty acids from oxidation by in-
terfering with the chain reaction of lipid peroxidation in the
membrane ((Singal et al., 1982; Packer, 1991). Furthermore, it
has the ability to limite myocardial necrosis (Axford-Gatley and
Wilson, 1991), and could protect the myocardium from infarc-
tion, when given in combination with vitamin C, as observed
in an experimental study in pigs (Klein et al., 1989), and also,
help to correct the depression of antioxidants that reported
to occur during ischemia nad hypoxia (Dhaliwal et al., 1991;
Kirshenbaum and   Singal, 1992). Furthermore, Cardiac depres-
sion during ischemia/reperfusion was prevented by using vi-
tamin E and superoxide dismutase (SOD) (Nagel et al., 1997;
Carrasquedo et al., 1999).
Vitamin E levels has been decreased in patients with coro-
nary artery bypass graft therapy, which was associated with
increased blood free radical levels (Grech et al., 1993). Treat-
ment of atherosclerotic patients with vitamin E reduced the
rale of myocardial infarction (Stephens et al., 1996). Also, the
risk of coronary artery disease in men and women was re-
duced after supplementing patients with vitamin E. On the
other hand, the production of free radicals by thr neurophils
was lowered after combined treatment of MI patients with vi-
tamin C and E (Herbaczynska-Cedro etal., 1995). Furthermore,
the infarct size was decreased, when a combination of vitamin
A, C, E and Bet carotene administered to patients with MI
(Singh et al., 1996). The protecting effect of vitamin E in case
of MI, may be attributed to its antioxidants properties or due
to its effect on smooth muscle cell proliferation that preserves
endothelial function (Chatelain et al., 1993 and Ozer et al.,
1995).
Conclusion
Oxidative stress may be involved in many cardiovascular
diseases including hypertension, ventricular hypertrophy, ath-
erosclerosis, congestive heart failure, myocardial infarction, is-
chemic reperfusion injury, coronary diseases and diabetic
cardiomyopathy. Antioxidants play an important role in releav-
ing the damage produced by free radical stress in the cardio-
vascular tissues.
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